RT

RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.

RTALB | IS

Overview

Corporate Details

ISIN(s):
TRERTAL00018
LEI:
Country:
Türkiye
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RTA Laboratuvarları, established in 1996, is a biotechnology company specializing in the research, development, and production of in-vitro diagnostic (IVD) products and biological pharmaceuticals. The company focuses on the fields of molecular biology and microbiology, utilizing its advanced R&D laboratories and expert personnel to develop a wide range of diagnostic kits and related biological materials. Its core activities include the production and distribution of domestic diagnostic solutions for the healthcare sector, with specific product lines in molecular biology, microbiology, and COVID-19 diagnostics. The company is committed to innovation and development in the molecular biotechnology field.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-27 16:10
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.09.2025)
Turkish 21.9 KB
2025-10-27 16:10
Quarterly Report
Faaliyet Raporu (30.09.2025)
Turkish 848.8 KB
2025-10-27 16:10
Report Publication Announcement
Faaliyet Raporu (30.09.2025)
Turkish 11.2 KB
2025-10-27 16:10
Quarterly Report
Financial Report
Turkish 1.9 MB
2025-10-27 16:10
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-08-11 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 52.9 KB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.06.2025)
Turkish 21.9 KB
2025-08-08 18:55
Interim Report
Faaliyet Raporu (30.06.2025)
Turkish 902.6 KB
2025-08-08 18:55
Report Publication Announcement
Faaliyet Raporu (30.06.2025)
Turkish 11.2 KB
2025-08-08 18:55
Interim Report
Financial Report
Turkish 1.9 MB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-07-07 11:10
Post-Annual General Meeting Information
2025 Yılı Bağımsız Denetim Şirketi Seçiminin Tescili ve İlanı
Turkish 29.4 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 414.9 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 672.0 KB
2025-07-07 11:08
Pre-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 14.5 KB

Automate Your Workflow. Get a real-time feed of all RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Oncopeptides Logo
Develops targeted therapies for hematological cancers using peptide-drug conjugate technology.
Sweden
ONCO
Onesano S.A. Logo
Develops patented nutritional products for humans, animals, and agriculture.
Poland
SKT
OnKure Therapeutics, Inc. Logo
Developing less toxic, tumor-agnostic kinase inhibitors for precision cancer therapy.
United States of America
OKUR
ONO PHARMACEUTICAL CO., LTD. Logo
Develops innovative medicines for high unmet needs in oncology, immunology, and neurology.
Japan
4528
OPKO Health Inc. Logo
Provides clinical diagnostics & develops novel therapies for serious & pediatric diseases.
Israel
OPK
OPKO HEALTH, INC. Logo
A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.
United States of America
OPK
Opthea Ltd Logo
Biopharma that discontinued its wet AMD therapy after its lead drug failed Phase 3 trials.
United States of America
OPT
OPTUS Pharmaceutical Co., Ltd. Logo
Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.
South Korea
131030
Opus Genetics, Inc. Logo
Developing gene therapies for inherited retinal diseases and other blinding conditions.
United States of America
IRD
ORAGENICS INC Logo
Biotech developing intranasal drugs for concussion and other brain disorders.
United States of America
OGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.